American Society of Clinical Oncology (ASCO) shared a post on X:
“This ASCOEdBook paper discusses the advances in targeted therapies and immunotherapies to treat PancreaticCancer and cautions that clinical trials should answer questions that matter to patients. By Kim Reiss Binder, Kevin Soares, Bishal Gyawali et al.”
Title: Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First
Authors։ Kim Reiss Binder, Kevin Soares, Bishal Gyawali
Read the Full Article.
Bishal Gyawali, Associate Professor at Queen’s University, shared a post by ASCO, adding:
“If you attended our session, you’ll enjoy this book chapter. If you missed our session, you can’t afford to miss this book chapter.”
More posts featuring ASCO.